Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (8594)	1/30/2002 3:48:59 PM
From: DaveAu	Read Replies (1) \| Respond to of 14101

Anyone, RK referred to the "Contract Sales Force" for Pennsaid. Should I assume this means they are paid only on commission and that we haven't been spending money on them other than to train them and prepare marketing materials ? Are the Dioptic guys not involved. If not, why do we keep that business? Dave

To: Joe Krupa who wrote (8594)	2/2/2002 11:07:44 PM
From: Cal Gary	Read Replies (2) \| Respond to of 14101

Hi Joe, Day 14 I got the 3 Banditos hedging $1.13mm and slowing down. There were a couple of days they did not trade at all. Check out TK's trading. They purchase 10.1K Friday, sold none. They also made purchases each day last week for a total of 23.5k shares. Perhaps their role has changed, for now, helping box in the price. I speculate that "they" have changed the terms of this draw. Again. Perhaps they've changed their minds every second day last week <g>. From another point of view, "they" maybe trying to figure out what the strength of demand and adjusting real time. Currently, my initial guess at the size of this draw can be termed "chucked out the window." Shattered. I still maintain that TK has a great opportunity at this time with FDA around the corner and a draw in progress, that they are some what in control of. Some days, I wish I could get some control over my portfolio.

To: Joe Krupa who wrote (8594)	2/3/2002 12:24:50 AM
From: axial	Read Replies (1) \| Respond to of 14101

Hi, Joe - "However, I still stick by my belief that Rebecca had a pretty good idea as to the likelihood of success when the trials wrapped up." Yup. Me too. I ran into a fellow DMX'r who quibbled about the info posted on the WF10 site. The essence of his argument was that the anecdotal information was unlikely to be trustworthy. I took the opposite view: in a notoriously conservative and reticent medical community, to find a physician who will speak out about an unproven drug's efficacy is rare. Furthermore, to find the physician maintaining the website (in effect, maintaining his advocacy of the drug's efficacy and continued usage) is an independent corroboration. If the results from the trials have come anywhere near matching the physician's results, that fact would quickly be manifested. I agree that Rebecca probably had a very good idea. ______________________________________ I also agree that the price of DMX likely dropped out of the preset "channel". Everyone has now moved to "Plan B": there is unsufficient volume, and they do not want to depress the price. "Plan B" of course, is to sell into the news... At least, I hope that's "Plan B"....!! Regards, Jim Edit - Just itchin' to type <snort>